Vitamin D and longevity: what your levels are doing to how you age

Most people in Northern Europe are walking around with a deficiency in something their body synthesises from sunlight — and a significant number have no idea. Around 40% of Europeans have 25-hydroxyvitamin D levels below 50 nmol/L, which is the threshold most clinical guidelines use to define adequacy. In countries further from the equator, the numbers are worse.

This is not a niche supplement concern. Vitamin D receptors are found in virtually every tissue in the body — heart, brain, immune cells, muscle, bone, pancreas. It’s less like a vitamin and more like a signalling hormone precursor, and there’s a reasonable body of evidence that having enough of it matters for how you age.

I’ll admit I was initially sceptical about this one. The supplement industry does a lot of breathless vitamin D marketing, which makes it easy to dismiss. Then I actually read the research.

What vitamin D actually is

The name is a bit misleading. Vitamin D3 (cholecalciferol) is technically a prohormone — your skin synthesises it from cholesterol when UVB radiation hits it, and then your liver and kidneys convert it into the active form, calcitriol. That active form then binds to vitamin D receptors (VDRs) in cells throughout the body, influencing gene expression in ways that affect immune function, inflammation, calcium metabolism, cell growth, and more.

Dr Michael Holick at Boston University has spent most of his career on this. His 2007 review in the New England Journal of Medicine — titled simply “Vitamin D Deficiency” — is still one of the clearest summaries of why widespread deficiency matters. His central argument is that VDRs being present in almost every tissue isn’t an accident; vitamin D is doing active regulatory work in most of your biology, not just in bone metabolism.

Calcium and bone health is what most people associate with vitamin D. That’s accurate but dramatically undersells it. The immune, anti-inflammatory, cardiovascular, and muscle-related roles are where the longevity implications get interesting.

The deficiency problem — especially up here

Munich sits at 48°N latitude. Most of the UK is between 51-58°N. At these latitudes, the sun angle from October through March is too low for UVB rays to penetrate the atmosphere in quantities sufficient for meaningful vitamin D synthesis in skin. Even on a bright winter’s day, being outside for an hour won’t significantly raise your levels.

From roughly April to September, meaningful synthesis is possible in sunny conditions — but with typical office schedules, sunscreen use, and the fact that Munich weather is not reliably Mediterranean, most people are nowhere near making up the deficit from summer months alone.

The seasonal consequence: blood levels for most Northern Europeans drop substantially through autumn and winter and recover only partially in summer. Even among people who consider themselves fairly healthy and active, levels below 50 nmol/L in February are common. I’ve seen my own numbers in a way that was slightly uncomfortable, given that I thought I’d been paying attention. Bit embarrassing, honestly.

If you’re British and living in Germany, as I am, the combination of pale skin that burns rather than tans and months of genuinely grey weather makes this particularly relevant. The sun in Munich in January is not doing anything useful for anyone’s D3 synthesis.

What the research shows

The observational data is consistent and fairly striking. Lower vitamin D levels are associated with higher all-cause mortality, higher cardiovascular risk, impaired immune function, and accelerated biological ageing across multiple large cohorts. These associations hold after adjustment for the obvious confounders.

The randomised trial data is more nuanced, which is worth being honest about.

The VITAL trial — published in the New England Journal of Medicine in 2019 — randomised 25,871 adults in the US to 2,000 IU of vitamin D3 per day or placebo for 5.3 years. The primary endpoints (major cardiovascular events and invasive cancer incidence) were not significantly reduced in the full cohort. However, cancer mortality was reduced by 25% in the vitamin D group (hazard ratio 0.75, 95% CI 0.58-0.96). That’s a hard outcome, not a biomarker shift — and it’s notable.

The VITAL results are not a failed trial. They’re a nuanced one. Many participants were already vitamin D sufficient at baseline, which likely blunted effects across the whole cohort. Pre-planned subgroup analyses showed stronger effects in people with lower baseline intake. The cancer mortality finding has held up to scrutiny and is the number I keep coming back to.

Where trial data is more consistent: immune function. A 2017 meta-analysis by Adrian Martineau and colleagues in the BMJ, drawing on individual participant data from 25 randomised controlled trials and 11,321 participants, found that vitamin D supplementation significantly reduced the risk of acute respiratory tract infections. The protective effect was strongest in people who were deficient at baseline — adjusted odds ratio of 0.70 for those with the most severe deficiency. That’s a rigorous analysis, not a loose observational association.

The mechanisms — how vitamin D affects ageing at the cellular level

The biological pathways linking vitamin D to longevity markers are better established than the clinical trial outcomes, which is part of why the research picture can feel a bit frustrating. We understand why it should work; the hard endpoint evidence takes longer to accumulate.

Inflammation. Active calcitriol suppresses the production of pro-inflammatory cytokines and promotes anti-inflammatory pathways. Deficient individuals consistently show higher circulating levels of C-reactive protein and other inflammatory markers. Since chronic low-grade inflammation is one of the central mechanisms of accelerated biological ageing, the anti-inflammatory effect of adequate vitamin D is directly relevant to longevity — not just to infection risk.

Telomere length. A 2007 study in the American Journal of Clinical Nutrition by Richards and colleagues found that women with higher serum 25(OH)D levels had significantly longer leukocyte telomeres. Telomere length is a marker of cellular ageing — shorter telomeres are associated with higher risk of age-related disease and earlier mortality. The association with vitamin D was independent of age and other confounders. Whether vitamin D directly slows telomere shortening or whether healthy people tend to have higher levels of both is debated; the association is consistent.

Immune regulation. Beyond acute infection risk, vitamin D is involved in regulating both innate and adaptive immune responses. VDRs are expressed on most immune cells. Active vitamin D modulates T-cell differentiation, promotes immune tolerance, and appears to reduce the risk of certain autoimmune conditions — including type 1 diabetes, multiple sclerosis, and rheumatoid arthritis, all of which show latitude-dependent prevalence that’s consistent with the vitamin D hypothesis.

Muscle function. Vitamin D receptors are present in skeletal muscle, and deficiency is associated with muscle weakness, increased fall risk, and worse recovery from muscle injury. This matters for longevity through several pathways — muscle mass is one of the most consistent predictors of healthy ageing and lower all-cause mortality, and vitamin D appears to support muscle protein synthesis and neuromuscular function, particularly in older adults. Grip strength, which Sarvita tracks as a biological age marker, has been shown to correlate with vitamin D status in multiple observational studies.

Cardiovascular function. VDRs in cardiac muscle and vascular endothelium respond to calcitriol. Vitamin D appears to regulate renin-angiotensin system activity — influencing blood pressure — and to support endothelial function. Whether this produces significant hard cardiovascular outcome reductions in well-powered trials is still being established, but the mechanistic rationale is solid.

Testing — what the numbers actually mean

The standard test is serum 25-hydroxyvitamin D (written as 25(OH)D) — a blood test available through GPs or via private testing. Results come in either nmol/L (used in Europe) or ng/mL (common in the US). To convert: multiply ng/mL by 2.5 to get nmol/L.

Current guideline categories (approximate — different bodies use slightly different thresholds):

• Deficiency: below 25 nmol/L (below 10 ng/mL)
• Insufficiency: 25-50 nmol/L (10-20 ng/mL)
• Sufficiency: above 50 nmol/L (above 20 ng/mL)
• Target for optimal function: 75-100 nmol/L (30-40 ng/mL) — the range advocated by Holick and others specifically for longevity outcomes

Most Northern Europeans who don’t actively supplement will be in insufficiency or deficiency range in winter. If you’ve never tested, it’s worth doing once — ideally in late winter (February or March) to capture your seasonal low point. That’s the honest number.

The test isn’t universally available on public health systems, but private blood tests for 25(OH)D are widely available and reasonably priced. Worth doing before starting a supplementation regimen and again three months in to see whether the dose is working.

Supplementation — the practical details

D3, not D2. Vitamin D3 (cholecalciferol) raises serum levels roughly twice as effectively as D2 (ergocalciferol) at equivalent doses. D3 is the form your skin produces naturally; D2 is derived from plant sources and used in some supplements and fortified foods. Check the label — some cheaper options default to D2.

Typical doses for Northern Europe:

• Maintenance through autumn and winter: 1,000-2,000 IU (25-50 mcg) daily
• Starting from confirmed deficiency: 4,000 IU daily for 8-12 weeks, then retest and reduce to maintenance
• Regulatory safe upper limits are generally set at 4,000 IU/day; higher doses should be supervised with regular testing

Take with fat. Vitamin D is fat-soluble. Taking it with a meal containing fat meaningfully increases absorption. There’s reasonable evidence that pairing it with your largest meal of the day improves bioavailability compared to taking it on an empty stomach.

K2 — worth knowing about. Vitamin D increases intestinal calcium absorption. Vitamin K2 (particularly the MK-7 form) helps ensure that absorbed calcium is directed to bones rather than soft tissue. The theoretical argument for combining them is sound; direct evidence in humans at typical supplement doses is more limited. That said, the combination is widely used, the additional risk is minimal, and if you’re supplementing D3 long-term, adding K2 at 100-200 mcg MK-7 is reasonable. Many combined supplements include both.

Magnesium. The enzymes that convert vitamin D to its active form are magnesium-dependent. Magnesium deficiency — which is more common than often assumed — can limit how effectively you convert D3 supplementation into active calcitriol. Most people eating a genuinely varied diet have adequate magnesium, but it’s worth being aware of the dependency if you’re supplementing D3 and not seeing expected level improvements.

Common mistakes

Assuming summer is enough. It might be, if you spent significant portions of it outdoors in direct sun — not behind glass, not in full-length clothing, not mostly inside an office. For most people with normal working schedules, summer sun partially rebuilds levels but doesn’t fully compensate for winter depletion, particularly if you’re fair-skinned and using sunscreen.

Thinking fatty fish covers it. A serving of salmon contains roughly 300-400 IU of vitamin D. The maintenance dose for most Northern Europeans is 1,000-2,000 IU. Three servings of fatty fish per week contributes usefully — and I’d recommend it anyway, given the omega-3 evidence — but it’s not a substitute for supplementation in low-sun climates. The numbers just don’t add up to sufficiency through diet alone.

Not retesting. If you supplement but never test, you don’t know whether you’ve hit a useful level. Retest after 3 months of consistent supplementation. Adjust the dose if needed. Test again in late winter to catch your seasonal low point. This sounds fiddly but it’s genuinely two blood tests a year.

Taking D2 because it was cheapest. Worth checking what’s in the bottle. D3 is not dramatically more expensive and is substantially more effective per IU. The label matters here.

What a practical protocol actually looks like

Test in late winter (February-March) to establish your baseline. If you’re below 50 nmol/L — which is common — start supplementing. If you’re between 50 and 75 nmol/L, a maintenance dose of 1,000-2,000 IU D3 daily through autumn and winter is sensible. If you’re below 25 nmol/L, a loading dose of 4,000 IU for a couple of months before dropping to maintenance is more appropriate.

Take it with fat, with K2 if you’re supplementing long-term. Retest after 3 months to confirm you’ve moved the number. Maintain supplementation through the winter months and taper off in summer if you’re getting meaningful sun exposure — or keep a lower maintenance dose year-round, which is simpler and perfectly reasonable.

A varied diet that includes regular fatty fish helps but won’t carry you alone at 48°N from October to April.

The practical bit

Vitamin D sits in an interesting position in longevity research: the observational associations are strong and biologically coherent, the mechanistic story is convincing, and the RCT evidence is accumulating but messier than the headlines suggest. The VITAL trial cancer mortality finding is real. The immune data from Martineau’s meta-analysis is solid. The telomere association is consistent.

What’s clear is that being deficient — which most Northern Europeans are for a significant portion of each year — is probably not doing your biology any favours across multiple systems simultaneously. The downside risk of correcting deficiency at sensible doses is minimal. The potential upside extends through immune function, inflammation, muscle health, and longer-term cancer and cardiovascular outcomes.

If you’re already doing most of the other things — exercising, sleeping enough, eating reasonably well — vitamin D is probably the supplement most worth actually thinking about. Not because it’s magic, but because the case for widespread genuine need in Northern Europe is genuinely strong, and the cost of correcting it is very low.

Test once. Supplement if needed. Retest. That’s the whole protocol.

Genuinely one of the easier longevity interventions. You just have to actually check the number first.